[1]
Pankiv, V. 2017. Advantages of the combined therapy with metformin and glimepiride in patients with type 2 diabetes mellitus. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine). 13, 2 (May 2017), 118–122. DOI:https://doi.org/10.22141/2224-0721.13.2.2017.100598.